ClinicalTrials.Veeva
Menu

Find clinical trials for Acute Myeloid Leukemia (AML) in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Acute Myeloid Leukemia
Leukemia
Myelodysplastic Syndromes
Myeloid Leukemia
Recurrence
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Hematologic Cancer

Acute Myeloid Leukemia (AML) trials near New Haven, CT, USA:

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia (TUSCANY)

to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...

Enrolling
Relapsed Adult AML
Leukemia, Myeloid, Acute
Drug: Venetoclax Oral Tablet
Drug: Tuspetinib

Phase 1, Phase 2

Aptose Biosciences

New Haven, Connecticut, United States and 33 other locations

allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...

Active, not recruiting
AML
Acute Myelogenous Leukemia
Drug: Iomab-B
Drug: Conventional Care

Phase 3

Actinium Pharmaceuticals
Actinium Pharmaceuticals

New Haven, Connecticut, United States and 23 other locations

Locations recently updated

medicine, and to evaluate its activity in treating certain types of acute myeloid leukemia (AML) in adults. The m...

Enrolling
AML (Acute Myeloid Leukemia)
Drug: CHM-029

Phase 1

Charm Therapeutics

New Haven, Connecticut, United States and 3 other locations

3) mutated Acute Myeloid Leukemia (AML).The names of the study drugs involved in this study are:* Revumenib (SNDX...

Enrolling
AML
AML, Adult
Drug: Daunorubicin
Drug: Cytarabine

Phase 1

Richard Stone, MD

New Haven, Connecticut, United States and 1 other location

a safe and effective treatment for people with relapsed/refractory AML with FLT3/IDH1 or FLT3/IDH2 gene mutations. The researchers will also...

Enrolling
Acute Myeloid Leukemia (AML)
Drug: Ivosidenib
Drug: Gilteritinib

Phase 1

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Commack, New York, United States and 6 other locations

Acute myeloid leukemia (AML) is an aggressive blood cancer, withwith few options for participants who relapse aft...

Enrolling
Acute Myeloid Leukemia
Drug: Pivekimab Sunirine

Phase 1

AbbVie
AbbVie

Valhalla, New York, United States and 13 other locations

Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...

Enrolling
Acute Myeloid Leukemia (AML)
Drug: Daunorubicin
Drug: Azacitidine (AZA)

Phase 3

Kura Oncology

New Haven, Connecticut, United States and 121 other locations

Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...

Enrolling
Myeloid Sarcoma
Nucleophosmin 1-mutated Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Cytarabine

Phase 1

Kura Oncology

New Haven, Connecticut, United States and 43 other locations

\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...

Enrolling
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Fludarabine

Phase 3

PedAL BCU, LLC

New Haven, Connecticut, United States and 89 other locations

in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults who ar...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Decitabine and Cedazuridine (ASTX727)
Drug: Venetoclax

Phase 1, Phase 2

Taiho Pharma
Taiho Pharma

New Haven, Connecticut, United States and 33 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems